Moors & Cabot’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,289
Closed -$236K 871
2021
Q1
$236K Sell
1,289
-5,267
-80% -$1.22M 0.02% 627
2020
Q4
$1.31M Buy
6,556
+1,114
+20% +$227K 0.11% 188
2020
Q3
$1.19M Buy
+5,442
New +$1.15M 0.11% 177

Other funds holding TDOC

Moors & Cabot's TDOC Position: Q2 2021 in Review

Moors & Cabot sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 1,289 shares — an estimated $236K sold.

Moors & Cabot first reported a position in TDOC in Q3 2020 and held it in 3 quarters. The position peaked at $1.31M in Q4 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Moors & Cabot reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Moors & Cabot sold 1,289 Teladoc Health shares in Q2 2021, an estimated $236K.
  • Moors & Cabot first reported a position in Teladoc Health in Q3 2020 and held it in 3 quarters.
  • Moors & Cabot's Teladoc Health position peaked at $1.31M in Q4 2020.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Moors & Cabot's 13F filing for Q2 2021, filed 10 Aug 2021.